Article Details

Bristol-Myers Squibb (NYSE:BMY) Receives Consensus Recommendation of "Buy" from Analysts

Retrieved on: 2021-07-06 14:15:00

Tags for this article:

Click the tags to see associated articles and topics

Bristol-Myers Squibb (NYSE:BMY) Receives Consensus Recommendation of "Buy" from Analysts. View article details on hiswai:

Excerpt

Finally, Truist Securities raised Bristol-Myers Squibb from a "hold" rating to a "buy" rating and lifted their price objective for the company from $66.00 to ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up